Nok Therapeutics, Inc.
New Filing
CIK: 0002038166·Biotechnology·FLORIDA·Filed: Oct 24, 2025
Total Offering
Indefinite
Amount Sold
$250,500
Investors
3
First Sale
Oct 8, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2024
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Robert Lewis | Related Person |
| Brian Cogley | Related Person |
| Bruce Cassidy | Related Person |
| Martin Lewis | Related Person |
| Michael Lewis | Related Person |
| David Mehalick | Related Person |
Company
SEC Filing
0001213900-25-102039
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free